Some very good news for people with asthma and COPD.
The first new treatment for acute attacks in over 50 years—
a monoclonal antibody vs interleukin-5 receptor-α—with efficacy in a randomized trial
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(24)00299-6/fulltext
The first new treatment for acute attacks in over 50 years—
a monoclonal antibody vs interleukin-5 receptor-α—with efficacy in a randomized trial
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(24)00299-6/fulltext
Comments
Go science!
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(24)00323-0/fulltext
"A new era in the treatment if acute exacerbations of asthma and COPD"
—No safety signals
—"the first rigorous and well-powered clinical trial of a biologic therapy to treat exacerbations" (<--which are very hard to do)